UBS/CALL/ROCHE GS/380.004/0.025/19.12.25 Share Price

Warrant

CROGQU

CH1147771203

Market Closed - Bid/Ask 08:50:00 27/05/2024 pm IST After market 08:45:00 pm
0.032 CHF +3.23% Intraday chart for UBS/CALL/ROCHE GS/380.004/0.025/19.12.25 0.04 +25.00%
1 month-20.00%
3 months-5.88%
Date Price Change
27/24/27 0.032 +3.23%
24/24/24 0.031 +3.33%

Delayed Quote Swiss Exchange

Last update May 27, 2024 at 08:50 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ROCHE HOLDING AG
Issuer UBS
CROGQU
ISINCH1147771203
Date issued 16/12/2021
Strike 380 CHF
Maturity 19/12/2025 (570 Days)
Parity 40 : 1
Emission price 1.15 CHF
Emission volume N/A
Settlement physical
Currency CHF

Technical Indicators

Highest since issue 1.48 CHF
Lowest since issue 0.03 CHF
Spread 0.019 CHF
Spread %38.78%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
229.9 CHF
Average target price
279.8 CHF
Spread / Average Target
+21.72%
Consensus
  1. Stock Market
  2. Warrants
  3. CROGQU Warrant